Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank94
5Y CAGR+27.4%
Year-over-Year Change
Year-over-year debt growth rate
5Y CAGR
+27.4%/yr
Long-term compound
Percentile
P94
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 37.01% |
| Q2 2025 | 3.46% |
| Q1 2025 | -0.52% |
| Q4 2024 | 2.65% |
| Q3 2024 | 3.19% |
| Q2 2024 | 2.32% |
| Q1 2024 | -2.22% |
| Q4 2023 | 5.23% |
| Q3 2023 | -4.53% |
| Q2 2023 | -18.33% |
| Q1 2023 | -25.67% |
| Q4 2022 | -11.23% |
| Q3 2022 | -34.23% |
| Q2 2022 | 4.75% |
| Q1 2022 | 4.54% |
| Q4 2021 | 8.43% |
| Q3 2021 | 31.31% |
| Q2 2021 | -10.15% |
| Q1 2021 | 1.20% |
| Q4 2020 | 72.63% |
| Q3 2020 | 11.01% |
| Q2 2020 | 43437.86% |
| Q1 2020 | -47.72% |
| Q4 2019 | -48.43% |
| Q3 2019 | -34.14% |
| Q2 2019 | -87.87% |
| Q1 2019 | 19.25% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |